Scholars Central

Conference abstractPublished 2 Nov 2015

Development of new antibiotics targeting shikimate kinase: From concept to practice

Authors: Concepción González-Bello

Universidad de Santiago de Compostela, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

According to the World Health Organization, antibiotic resistance is becoming a public health emergency of unknown proportions. Therefore, there is a great interest in the discovery of novel drugs and therapies to tackle antimicrobial resistance, in particular drugs that target unexplored essential processes for bacterial survival. For this purpose, a detailed knowledge of the catalytic mechanism, the binding determinants and the essential motion for catalytic turnover of selected enzymes involved in biosynthetic pathways or processes that do not have mammalian homologs, but are essential for bacterial survival, can be valuable for the rational design of these mimetics (inhibitors) that can be used as drugs. Our research group is studying the possible development of new antibiotics whose mode of action is based on the selective and effective inhibition of an essential enzyme in bacteria that does not have any counterpart in human cells, shikimate kinase (SK). This enzyme is essential in relevant pathogenic bacteria such as Mycobacterium tuberculosis, Helicobacter pylori and Pseudomonas aeruginosa and catalyzes the stereospecific phosphorylation of the C3 hydroxyl group of shikimic acid by transferring the Ã?³-phosphate group of ATP to the hydroxyl group to provide shikimate 3-phosphate and ADP. Here, we report results from NMR, biochemical, structural and molecular dynamics simulation studies that help understand the catalytic mechanism of the SK enzyme. Based on these results, several competitive inhibitors of the enzyme were designed. Our recent results on this project will be presented.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal Chemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Concepción González-Bello”